Side-by-side comparison of AI visibility scores, market position, and capabilities
European B2B go-to-market platform combining website visitor tracking and company intelligence. Helsinki/Karlsruhe, raised €180M+, formed from merger of Leadfeeder and Echobot.
Dealfront is a European B2B go-to-market platform formed from the merger of Leadfeeder and Echobot, combining website visitor tracking, company intelligence, and prospecting tools for revenue teams. Headquartered across Helsinki, Finland and Karlsruhe, Germany, the company has raised over €180 million in funding. Dealfront identifies the companies visiting a prospect's website — even anonymous visitors who don't fill out a form — and enriches those visits with firmographic data, contact information, and intent signals to create a qualified prospect list.\n\nDealfront's website visitor identification technology resolves anonymous IP traffic to company identities, providing marketing and sales teams with a list of businesses that have shown purchase intent by visiting their website. Integration with CRM systems allows these visitor records to sync as new leads or update existing accounts, triggering sales sequences or marketing nurture campaigns based on visit behavior. The platform's European company data — inherited from Echobot's deep DACH region coverage — provides particularly strong firmographic and contact data for German, Austrian, and Swiss markets.\n\nDealfront's European focus is a key differentiator — the platform is built with GDPR compliance as a foundational requirement and provides the strongest B2B data coverage for European markets compared to US-centric alternatives. Revenue teams with significant European go-to-market motions benefit from the combination of website intent identification, European firmographic data, and contact information that allows faster follow-up on warm inbound signals from prospect companies.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.